Literature DB >> 22136934

Heart drugs that affect bone.

Jennifer S Walsh1, Chris Newman, Richard Eastell.   

Abstract

There have been important developments in our understanding of the mechanisms underlying the development of osteoporosis, and several of these mechanisms also underlie atherosclerosis. Drugs given to treat cardiovascular disease may impact on bone health in either a beneficial or a harmful way. There is evidence that nitrates are beneficial to bone, but evidence for the benefit of statins, thiazide diuretics, and β-blockers is weaker. By contrast, it is likely to be that some drugs such as loop-acting diuretics are harmful to bone, whereas evidence for harm caused by drugs such as warfarin is weaker. These observations point towards opportunities for new drug development for bone diseases, and possibly the development of treatments that will benefit more than one disease. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22136934     DOI: 10.1016/j.tem.2011.10.002

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  7 in total

1.  In vivo assessment of bone quality in postmenopausal women with type 2 diabetes.

Authors:  Joshua N Farr; Matthew T Drake; Shreyasee Amin; L Joseph Melton; Louise K McCready; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

2.  Warfarin use and fracture risk: an evidence-based mechanistic insight.

Authors:  T Sugiyama; F Kugimiya; S Kono; Y T Kim; H Oda
Journal:  Osteoporos Int       Date:  2014-10-10       Impact factor: 4.507

3.  Ligand Activation of ERRα by Cholesterol Mediates Statin and Bisphosphonate Effects.

Authors:  Wei Wei; Adam G Schwaid; Xueqian Wang; Xunde Wang; Shili Chen; Qian Chu; Alan Saghatelian; Yihong Wan
Journal:  Cell Metab       Date:  2016-01-14       Impact factor: 27.287

4.  Prolonged Diuretic Activity and Calcium-Sparing Effect of Tropaeolum majus: Evidence in the Prevention of Osteoporosis.

Authors:  Lorena Neris Barboza; Thiago Bruno Lima Prando; Paulo Roberto Dalsenter; Francielly Mourão Gasparotto; Francielli Gasparotto; Ezilda Jacomassi; Valdinei de Oliveira Araújo; Emerson Luiz Botelho Lourenço; Arquimedes Gasparotto Junior
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-16       Impact factor: 2.629

5.  Effect of vitamin D3 on bone turnover markers in critical illness: post hoc analysis from the VITdAL-ICU study.

Authors:  V Schwetz; C Schnedl; T Urbanic-Purkart; C Trummer; H P Dimai; A Fahrleitner-Pammer; C Putz-Bankuti; K B Christopher; B Obermayer-Pietsch; T R Pieber; H Dobnig; K Amrein
Journal:  Osteoporos Int       Date:  2017-08-25       Impact factor: 4.507

Review 6.  Common mechanisms and holistic care in atherosclerosis and osteoporosis.

Authors:  Zoltán Szekanecz; Hennie G Raterman; Zsófia Pethő; Willem F Lems
Journal:  Arthritis Res Ther       Date:  2019-01-10       Impact factor: 5.156

7.  The effects of antihypertensive drugs on bone mineral density in ovariectomized mice.

Authors:  Kwi Young Kang; Yoongoo Kang; Mirinae Kim; Youngkyun Kim; Hyoju Yi; Juryun Kim; Hae-Rin Jung; Sung-Hwan Park; Ho-Youn Kim; Ji Hyeon Ju; Yeon Sik Hong
Journal:  J Korean Med Sci       Date:  2013-07-31       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.